These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19473632)

  • 1. Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24.
    Rauen T; Michaelis A; Floege J; Mertens PR
    Clin Nephrol; 2009 Jun; 71(6):637-42. PubMed ID: 19473632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.
    Bomback AS; Tumlin JA; Baranski J; Bourdeau JE; Besarab A; Appel AS; Radhakrishnan J; Appel GB
    Drug Des Devel Ther; 2011 Mar; 5():147-53. PubMed ID: 21448451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.
    van de Logt AE; Beerenhout CH; Brink HS; van de Kerkhof JJ; Wetzels JF; Hofstra JM
    PLoS One; 2015; 10(11):e0142033. PubMed ID: 26562836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH and azathioprine: antiproteinuric and lipid-lowering effect in the course of idiopathic membranous glomerulonephritis.
    Gigante A; Rosato E; Liberatori M; Gasperini ML; Giannakakis K; Barbano B; Cianci R; Salsano F; Amoroso A
    J Biol Regul Homeost Agents; 2012; 26(1):135-8. PubMed ID: 22475105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?
    Ahuja M; Goumenos D; Shortland JR; Gerakis A; Brown CB
    Am J Kidney Dis; 1999 Sep; 34(3):521-9. PubMed ID: 10469864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.
    Berg AL; Nilsson-Ehle P; Arnadottir M
    Kidney Int; 1999 Oct; 56(4):1534-43. PubMed ID: 10504505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS; Canetta PA; Beck LH; Ayalon R; Radhakrishnan J; Appel GB
    Am J Nephrol; 2012; 36(1):58-67. PubMed ID: 22722778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
    Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
    BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
    Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H
    BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
    Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
    J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and clinical significance of glomerular M-type phospholipase A
    Liu H; Luo W; Gong S; Ding X
    Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
    Hladunewich MA; Cattran D; Beck LH; Odutayo A; Sethi S; Ayalon R; Leung N; Reich H; Fervenza FC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1570-7. PubMed ID: 24714414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
    Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
    Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
    Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
    Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.